ID | 蛋白ID | Accession | GN:Name | DE:Name | GeneID |
59252 | CD80_HUMAN | P33681; Q5DTA9; Q5DTB0 | CD80 | T-lymphocyte activation antigen CD80; Activation B7-1 antigen; BB1; CTLA-4 counter-receptor B7.1; B7; CD80 | 941 |
59251 | CD7_MOUSE | P50283 | Cd7 | T-cell antigen CD7; CD7 | 12516 |
59250 | CD7_HUMAN | P09564 | CD7 | T-cell antigen CD7; GP40; T-cell leukemia antigen; T-cell surface antigen Leu-9; TP41; CD7 | 924 |
59249 | CD79B_MOUSE | P15530; Q4FJP4 | Cd79b | B-cell antigen receptor complex-associated protein beta chain; B-cell-specific glycoprotein B29; Ig-beta; Immunoglobulin-associated B29 protein; CD79b | 15985 |
59248 | CD79B_HUMAN | P40259; Q53FS2; Q9BU06 | CD79B | B-cell antigen receptor complex-associated protein beta chain; B-cell-specific glycoprotein B29; Ig-beta; Immunoglobulin-associated B29 protein; CD79b | 974 |
59247 | CD79A_MOUSE | P11911; Q6GTY0 | Cd79a | B-cell antigen receptor complex-associated protein alpha chain; Ig-alpha; MB-1 membrane glycoprotein; Membrane-bound immunoglobulin-associated protein; Surface IgM-associated protein; CD79a | 12518 |
59246 | CD79A_HUMAN | A0N775; P11912; Q53FB8 | CD79A | B-cell antigen receptor complex-associated protein alpha chain; Ig-alpha; MB-1 membrane glycoprotein; Membrane-bound immunoglobulin-associated protein; Surface IgM-associated protein; CD79a | 973 |
59245 | CD79A_CANLF | P0CAN6 | CD79A | B-cell antigen receptor complex-associated protein alpha chain; Ig-alpha; CD79a | 484483 |
59244 | CD79A_BOVIN | P40293; Q0P5B8; Q28134 | CD79A | B-cell antigen receptor complex-associated protein alpha chain; Ig-alpha; MB-1 membrane glycoprotein; Membrane-bound immunoglobulin-associated protein; Surface IgM-associated protein; CD79a | 281674 |
59243 | CD72_MOUSE | A2AIN6; P21855; Q64225 | Cd72 | B-cell differentiation antigen CD72; Lyb-2; Lymphocyte antigen 32; Ly-32; CD72 | 12517 |
59242 | CD72_HUMAN | P21854 | CD72 | B-cell differentiation antigen CD72; Lyb-2; CD72 | 971 |
59241 | CD70_PIG | Q3ZDR4 | CD70 | CD70 antigen; CD27 ligand; CD27-L; Tumor necrosis factor ligand superfamily member 7; CD70 | 733577 |
59240 | CD70_MOUSE | O55237 | Cd70 | CD70 antigen; CD27 ligand; CD27-L; Tumor necrosis factor ligand superfamily member 7; CD70 | 21948 |
59239 | CD70_HUMAN | B4DPR8; P32970; Q53XX4; Q96J57 | CD70 | CD70 antigen; CD27 ligand; CD27-L; Tumor necrosis factor ligand superfamily member 7; CD70 | 970 |
59238 | CD6_MOUSE | Q60679; Q61003; Q61004; Q8BGK1 | Cd6 | T-cell differentiation antigen CD6; CD6 | 12511 |
59237 | CD6_HUMAN | A4KAD4; A4KAD5; P30203; Q8WWJ3; Q8WWJ4; Q8WWJ5; Q8WWJ6; Q8WWJ7; Q9UMF2 | CD6 {ECO:0000312|HGNC:HGNC:1691} | T-cell differentiation antigen CD6 {ECO:0000305}; T12; TP120; CD6 | 923 |
59236 | CD69_MOUSE | P37217 | Cd69 | Early activation antigen CD69; CD69 | 12515 |
59235 | CD69_HUMAN | Q07108 | CD69 | Early activation antigen CD69; Activation inducer molecule; AIM; BL-AC/P26; C-type lectin domain family 2 member C; EA1; Early T-cell activation antigen p60; GP32/28; Leukocyte surface antigen Leu-23; MLR-3; CD69 | 969 |
59234 | CD68_MOUSE | O54688; O70321; P31996; Q3S4A9; Q5F2A8; Q9DD15 | Cd68 | Macrosialin; CD68 | 12514 |
59233 | CD68_HUMAN | B4DVT4; P34810; Q53HR6; Q53XI3; Q96BI7 | CD68 | Macrosialin; Gp110; CD68 | 968 |
59232 | CD63_RAT | P28648 | Cd63 | CD63 antigen; Mast cell antigen AD1; CD63 | 29186 |
59231 | CD63_RABIT | Q28709 | CD63 | CD63 antigen; CD63 | 100008988 |
59230 | CD63_MOUSE | P41731 | Cd63 | CD63 antigen; CD63 | 12512 |
59229 | CD63_HUMAN | F8VZE2; P08962; Q5TZP3; Q8N6Z9; Q9UCG6 | CD63 | CD63 antigen; Granulophysin; Lysosomal-associated membrane protein 3 {ECO:0000303|PubMed:10793155, ECO:0000303|PubMed:1939168}; LAMP-3 {ECO:0000303|PubMed:10793155, ECO:0000303|PubMed:1939168}; Lysosome integral membrane protein 1 {ECO:0000303|PubMed:1939168}; Limp1 {ECO:0000303|PubMed:1939168}; Melanoma-associated antigen ME491 {ECO:0000303|PubMed:1599482, ECO:0000303|PubMed:1939168}; OMA81H; Ocular melanoma-associated antigen; Tetraspanin-30; Tspan-30; CD63 | 967 |
59228 | CD63_FELCA | Q76B49 | CD63 | CD63 antigen; CD63 | 493846 |
59227 | CD63_BOVIN | Q3SZY2; Q9XSK2 | CD63 | CD63 antigen; CD63 | 404156 |
59226 | CD5_RAT | P51882; Q63098 | Cd5 | T-cell surface glycoprotein CD5; CD5 | 54236 |
59225 | CD5_MOUSE | P13379 | Cd5 | T-cell surface glycoprotein CD5; Lymphocyte antigen 1; Ly-1; Lyt-1; CD5 | 12507 |
59224 | CD5_HUMAN | A0N0P4; A8K9I3; P06127 | CD5 | T-cell surface glycoprotein CD5; Lymphocyte antigen T1/Leu-1; CD5 | 921 |
59223 | CD5_BOVIN | P19238; Q2HJA1 | CD5 | T-cell surface glycoprotein CD5; CD5 | 280745 |
59222 | CD5R2_MOUSE | O35277; O35926; Q9QYD1 | Cdk5r2 | Cyclin-dependent kinase 5 activator 2; CDK5 activator 2; Cyclin-dependent kinase 5 regulatory subunit 2; p39; p39I | 12570 |
59221 | CD5R2_HUMAN | Q13319; Q4ZFW6 | CDK5R2 | Cyclin-dependent kinase 5 activator 2; CDK5 activator 2; Cyclin-dependent kinase 5 regulatory subunit 2; p39; p39I | 8941 |
59220 | CD5R1_SPECI | Q4KYY2 | CDK5R1 | Cyclin-dependent kinase 5 activator 1; CDK5 activator 1; Cyclin-dependent kinase 5 regulatory subunit 1 | 0 |
59219 | CD5R1_RAT | P61810; Q62938 | Cdk5r1 | Cyclin-dependent kinase 5 activator 1; CDK5 activator 1; Cyclin-dependent kinase 5 regulatory subunit 1; TPKII regulatory subunit; p35; p25; Tau protein kinase II 23 kDa subunit; p23 | 116671 |
59218 | CD5R1_MOUSE | P61809; Q62938 | Cdk5r1 | Cyclin-dependent kinase 5 activator 1; CDK5 activator 1; Cyclin-dependent kinase 5 regulatory subunit 1; TPKII regulatory subunit; p35; p25; Tau protein kinase II 23 kDa subunit; p23 | 12569 |
59217 | CD5R1_HUMAN | E1P664; Q15078; Q5U0G3 | CDK5R1 | Cyclin-dependent kinase 5 activator 1; CDK5 activator 1; Cyclin-dependent kinase 5 regulatory subunit 1; TPKII regulatory subunit; p35; p25; Tau protein kinase II 23 kDa subunit; p23 | 8851 |
59216 | CD5R1_CAEEL | Q0G843; Q22695 | cdka-1 {ECO:0000312|WormBase:T23F11.3a} | Cyclin-dependent kinase 5 activator 1; p35 {ECO:0000305|PubMed:17671168} | 188812 |
59215 | CD5R1_BOVIN | Q0II69; Q28199; Q28865; Q29462 | CDK5R1 | Cyclin-dependent kinase 5 activator 1; CDK5 activator 1; Cyclin-dependent kinase 5 regulatory subunit 1; TPKII regulatory subunit; p35; p25; Tau protein kinase II 23 kDa subunit; p23 | 282173 |
59214 | CD5L_MOUSE | O35300; O35301; Q3TXN5; Q505P6; Q91W05; Q9QWK4 | Cd5l | CD5 antigen-like; Apoptosis inhibitor expressed by macrophages {ECO:0000303|PubMed:9892623}; mAIM {ECO:0000303|PubMed:23236605}; Apoptosis inhibitory 6; SP-alpha {ECO:0000303|PubMed:10651944} | 11801 |
59213 | CD5L_HUMAN | A8K7M5; O43866; Q6UX63 | CD5L | CD5 antigen-like; Apoptosis inhibitor expressed by macrophages {ECO:0000303|PubMed:23236605}; hAIM {ECO:0000303|PubMed:23236605}; CT-2 {ECO:0000303|Ref.2}; IgM-associated peptide {ECO:0000303|PubMed:8034987}; SP-alpha {ECO:0000303|PubMed:9045627} | 922 |
59212 | CD59_SHV21 | Q00996 | 15 | Surface glycoprotein CD59 homolog | 1682506 |
59211 | CD59_SHEEP | P58020; Q9TRH4 | CD59 | CD59 glycoprotein; Complement inhibitory protein; CIP; MAC-inhibitory protein; MAC-IP; Membrane attack complex inhibition factor; MACIF; Protectin; CD59 | 0 |
59210 | CD59_SAISC | P47777 | CD59 | CD59 glycoprotein; MAC-inhibitory protein; MAC-IP; Membrane attack complex inhibition factor; MACIF; Protectin; CD59 | 0 |
59209 | CD59_RAT | P27274 | Cd59 | CD59 glycoprotein; MAC-inhibitory protein; MAC-IP; Membrane attack complex inhibition factor; MACIF; Protectin; CD59 | 25407 |
59208 | CD59_RABIT | O77541 | CD59 | CD59 glycoprotein; MAC-inhibitory protein; MAC-IP; Membrane attack complex inhibition factor; MACIF; Protectin; CD59 | 100009459 |
59207 | CD59_PONAB | Q5R510 | CD59 | CD59 glycoprotein; MAC-inhibitory protein; MAC-IP; Membrane attack complex inhibition factor; MACIF; Protectin; CD59 | 100173870 |
59206 | CD59_PIG | O62680; Q9TR76; Q9XT94 | CD59 | CD59 glycoprotein; MAC-inhibitory protein; MAC-IP; Membrane attack complex inhibition factor; MACIF; Protectin; CD59 | 397347 |
59205 | CD59_PAPSP | Q28785 | CD59 | CD59 glycoprotein; MAC-inhibitory protein; MAC-IP; Membrane attack complex inhibition factor; MACIF; Protectin; CD59 | 0 |
59204 | CD59_MACFA | Q4R5M6; Q8SPI3; Q8SQ46 | CD59 | CD59 glycoprotein; MAC-inhibitory protein; MAC-IP; Membrane attack complex inhibition factor; MACIF; Protectin; CD59 | 101867071 |
59203 | CD59_HUMAN | E9PR17; P13987 | CD59 | CD59 glycoprotein; 1F5 antigen; 20 kDa homologous restriction factor; HRF-20; HRF20; MAC-inhibitory protein; MAC-IP; MEM43 antigen; Membrane attack complex inhibition factor; MACIF; Membrane inhibitor of reactive lysis; MIRL; Protectin; CD59 | 966 |